SALT LAKE CITY, UT / ACCESSWIRE / February 5, 2016 / Compass Biotechnologies Inc. (OTC PINK: COBI) (PINKSHEETS: COBI) (Compass) is pleased to announce the previously mentioned acquisition target is efsAUDIO Inc., manufacturer of the Motion Sound product line. Since 1994, Motion Sound products have been developed and manufactured with the focus on innovation, quality, reliability and tone. Motion Sound amplifiers are recognized as an industry standard through their quality and innovation in proprietary rotary speaker technology and stereo amplification for organs, pianos and synthesizers. Motion Sound keyboard and guitar amplifiers are used and endorsed by well-known artists throughout the world. To view a list of artists, please visit the Motion Sound web site at www.msamps.com.

The completion of the acquisition of efsAUDIO is expected late next week, which will result in efsAUDIO becoming a subsidiary of Compass. The Company will effect a name change to reflect its new business direction after the acquisition is completed.

It has come to our attention that several recent inquiries have gone unanswered due to technical difficulties with our email system and investor phone line. We would like to apologize for any absence in communications, and these issues have been rectified.

Compass Biotechnologies Inc., (OTC PINKSHEETS: COBI.PK)

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Person:

Rick Shykora
At: compassbiotechnologies@gmail.com
(972) 535-8931

SOURCE: Compass Biotechnologies Inc.